As of February 2025 Galectin Therapeutics has a market cap of €89.05 Million. This makes Galectin Therapeutics the world's 9098th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Feb 21st, 2025 the market cap of Galectin Therapeutics was reported to be: